MENDUS AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4485 SEK | -5.38% |
|
-8.47% | -14.24% |
| 16/04 | Mendus AB Announces Board Changes | CI |
| 27/03 | Mendus AB Announces Ethics Committee Approval for the AMLM22-CADENCE Trial with Lead Product Vididencel in AML | CI |
Chart calendar Mendus AB
7d778e1433f6c304c8ccb.1GIdwRJe7SJd0ChO9OE8u1Hs6avUsF2XT6AgXQ_REEg.4QdZjVALgFsk_XkIw7sPjxCuvMiEhG_cJ5RuZVrmJTqbMGX0WS6se2m1Tw~e81af855534abb0648b27ad9c6806662
Upcoming events on Mendus AB
Past events on Mendus AB
| 19/03/2024 | Innate Killer Summit |
| 12/03/2024 07:30 pm | Business Update Call |
| 27/02/2024 | IO360° Summit |
| 14/02/2024 02:30 pm | Q4 2023 Earnings Call |
| 14/02/2024 12:30 pm | Q4 2023 Earnings Release |
| 24/01/2024 03:25 pm | Redeye Theme: Fight Cancer |
| 08/01/2024 | LifeSci Partners Corporate Access Event |
| 08/01/2024 | JPMorgan Healthcare Conference |
| 14/12/2023 07:30 pm | Investor Meeting - Key Opinion Leader |
| 13/12/2023 08:30 pm | Extraordinary Shareholders Meeting |
| 12/12/2023 12:00 am | American Society of Hematology Meeting - Abstract No:769 |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No:2942 |
| 11/12/2023 07:30 am | American Society of Hematology Meeting - Abstract No:2957 |
| 05/12/2023 04:10 pm | Cell & Gene Therapy Manufacturing & Commercialization Conference |
| 23/11/2023 09:00 pm | Redeye Life Science Day |
| 21/11/2023 | Belgian Dutch Immunology Meeting |
| 14/11/2023 | Jefferies London Healthcare Conference |
| 13/11/2023 | Investival Showcase |
| 09/11/2023 02:30 pm | Q3 2023 Earnings Call |
| 09/11/2023 12:30 pm | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million SEK | Released Forecast Spread | 0,00 0,00 - | 0,00 | 0,03 0,00 - | 3,38 1,61 110.15% | 29,6 0,41 7149.2% | 0,00 |
|
EBITDA Million SEK | Released Forecast Spread | -132 -120 -10.36% | 0,00 | -130 -130 0.17% | -132 -127 -3.62% | -89,8 -115 22.17% | -129 |
|
EBIT Million SEK | Released Forecast Spread | -132 -120 -10.36% | -86,0 | -130 -130 0.17% | -134 -127 -4.97% | -101 -117 14.23% | -130 |
|
Earnings before Tax (EBT) Million SEK | Released Forecast Spread | -134 -120 -11.78% | -89,2 | -133 -132 -1.15% | -139 -129 -7.21% | -102 -106 4.2% | -130 |
|
Net income Million SEK | Released Forecast Spread | -134 -120 -11.78% | -89,2 | -133 -132 -1.15% | -139 -129 -7.21% | -102 -106 4.2% | -130 |
|
EPS SEK | Released Forecast Spread | -1,50 -1,34 -11.94% | -1,17 | -0,73 -0,68 -8.15% | -0,70 -0,63 -11.11% | -0,22 -0,14 -57.14% | -0,12 |
| Announcement Date | 18/02/20 | 18/02/21 | 17/02/22 | 17/02/23 | 14/02/24 | - |
| Today 04:00 pm | UNITED THERAPEUTICS CORPORATION: Q1 2024 Earnings Release |
| Today 04:00 pm | BIO-TECHNE CORPORATION: Q3 2024 Earnings Release |
| Today 04:30 pm | ALKERMES PLC: Q1 2024 Earnings Release |
| 02/05/2024 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | CELLDEX THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | MIRUM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | INTELLIA THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
Past sector events for Mendus AB
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- IMMU Stock
- Calendar Mendus AB
